文献速递复苏、休克与脓毒症消化、代谢与肾脏急症

评估急诊科成人脓毒症事件标准的诊断性能:纳入孤立性血清乳酸升高的影响

Evaluating the diagnostic performance of adult sepsis event criteria in the emergency department: impact of including isolated serum lactate elevations.
PubMed 文献 · J Intensive Care · 2025-08-15
一句话结论在急诊疑似感染患者中,CDC成人脓毒症事件(ASE)定义的eSOFA与Sepsis-3中度一致(敏感性52.0%、特异性94.2%),扩展eSOFA纳入孤立性乳酸≥2.0 mmol/L可提高敏感性至64.3%但降低特异性至80.6%。

该研究回顾性分析了三家机构急诊科2023年9月1日至30日收治的698例疑似感染成人患者(年龄≥19岁),所有患者均留取血培养。按Sepsis-3标准(SOFA评分较基线升高≥2分)和ASE定义的eSOFA(血培养采集前后±2天内出现器官功能障碍)分类,扩展eSOFA额外纳入孤立性乳酸升高(≥2.0 mmol/L)。结果显示,456例(65.3%)符合Sepsis-3,251例(35.9%)符合ASE定义的eSOFA,340例(48.7%)符合扩展eSOFA;同时符合SOFA和eSOFA的患者死亡率最高(19.8%)。ASE定义的eSOFA敏感性52.0%、特异性94.2%、阳性预测值94.4%;扩展eSOFA敏感性提高至64.3%但特异性降至80.6%。随着功能障碍器官类别数增加,死亡率升高;纳入孤立性乳酸升高可识别eSOFA未捕获的额外高危患者。

要点

  • 在698例急诊疑似感染成人中,ASE定义的eSOFA诊断脓毒症的敏感性为52.0%、特异性为94.2%、阳性预测值为94.4%。
  • 扩展eSOFA(纳入孤立性乳酸≥2.0 mmol/L)将敏感性提高至64.3%,但特异性降至80.6%。
  • 同时符合Sepsis-3和eSOFA的患者死亡率最高,为19.8%。
  • 随着功能障碍器官类别数增加,患者死亡率升高。
  • 纳入孤立性乳酸升高可识别eSOFA未捕获的额外高危急诊患者。

适用人群与场景

  • 年龄≥19岁、疑似感染且留取血培养的急诊科患者,来自三家机构,数据收集时间为2023年9月1日至30日。

诊断标准与关键阈值

  • Sepsis-3标准:SOFA评分较基线升高≥2分。
  • ASE定义的eSOFA:血培养采集前后±2天内出现器官功能障碍。
  • 扩展eSOFA:在eSOFA基础上额外纳入孤立性乳酸升高(≥2.0 mmol/L)。

研究设计与关键结果

  • 回顾性研究,纳入698例急诊疑似感染成人患者,来自三家机构;456例(65.3%)符合Sepsis-3标准,251例(35.9%)符合ASE定义的eSOFA,340例(48.7%)符合扩展eSOFA。
  • ASE定义的eSOFA敏感性52.0%、特异性94.2%、阳性预测值94.4%;扩展eSOFA敏感性64.3%、特异性80.6%。
  • 同时符合SOFA和eSOFA的患者死亡率最高,为19.8%;随着功能障碍器官类别数增加,死亡率升高。
  • 纳入孤立性乳酸升高可识别eSOFA未捕获的额外高危患者。

证据类型、等级与局限

  • 证据类型:回顾性研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,ASE定义的eSOFA与Sepsis-3标准中度一致,能有效识别高危急诊脓毒症病例。
  • 作者认为,扩展eSOFA纳入乳酸可提高敏感性但降低特异性,建议根据临床环境和可用资源针对性应用。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: The Adult Sepsis Event (ASE) criteria, developed by the US. Centers for Disease Control and Prevention (CDC), utilize electronic Sequential Organ Failure Assessment (eSOFA) scores derived from structured electronic health records to retrospectively detect organ dysfunction in patients with suspected sepsis. While validated primarily in inpatient cohorts, their applicability in emergency department (ED) populations remains uncertain. Moreover, the impact of including isolated serum lactate elevation as a marker of organ dysfunction in eSOFA has not been systematically evaluated.

METHODS: We retrospectively reviewed data from 698 patients (aged ≥ 19 years) with suspected infections presenting to the EDs of three institutions from September 1 to 30, 2023. Blood cultures were obtained from all patients. Patients were classified according to Sepsis-3 (≥ 2-point SOFA score increase from baseline) and ASE-defined eSOFA (organ dysfunction occurring within ± 2 days of blood culture collection). Extended eSOFA additionally included isolated lactate elevation (≥ 2.0 mmol/L). Diagnostic performance was assessed using sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV).

RESULTS: Among 698 patients, 456 (65.3%) met Sepsis-3 criteria, 251 (35.9%) met ASE-defined eSOFA, and 340 (48.7%) met extended eSOFA criteria. Mortality was highest (19.8%) among patients classified by both SOFA and eSOFA. ASE-defined eSOFA demonstrated moderate sensitivity (52.0%) and high specificity (94.2%), with a PPV of 94.4%. Extended eSOFA improved sensitivity (64.3%) but lowered specificity (80.6%). Mortality increased with the number of dysfunctional organ categories. Notably, the inclusion of isolated lactate elevations identified additional high-risk patients not captured by eSOFA.

CONCLUSION: ASE-defined eSOFA moderately aligns with Sepsis-3 criteria, effectively identifying high-risk ED sepsis cases. Extended eSOFA criteria with lactate enhance sensitivity but reduce specificity, suggesting tailored application based on clinical settings and available resources.

来源:J Intensive Care,查看原文。版权归原作者所有。

参考来源

  1. Park H, Ko RE, Oh HS, et al. Evaluating the diagnostic performance of adult sepsis event criteria in the emergency department: impact of including isolated serum lactate elevations. J Intensive Care. 2025. PMID: 40817240. doi:10.1186/s40560-025-00815-w

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。